Healthcare AI Acquisition Corp.(HAIAU) - 2021 Q4 - Annual Report

Financial Condition - As of December 31, 2021, the company had $2,500,000 in its operating bank account and working capital of $981,412, raising substantial doubt about its ability to continue as a going concern [212]. - The net proceeds from the initial public offering, over-allotment, and the sale of private placement warrants amounted to $222,436,490, including $196,000,000 from the IPO after underwriting costs [215]. - The company may incur substantial debt to complete its initial business combination, which could adversely affect its leverage and financial condition [213]. - The company may face challenges in completing an initial business combination due to compliance obligations under the Sarbanes-Oxley Act, which could increase time and costs [237]. - The company may be required to take write-downs or other charges post-business combination, which could negatively impact financial condition and results of operations [241]. - The company may experience reduced liquidity and limited market quotations for its securities, which could classify its Class A ordinary shares as "penny stock," leading to stricter trading rules [275]. Business Combination Risks - The company may only be able to complete one business combination, leading to a lack of diversification that could negatively impact operations and profitability [215]. - The absence of a specified maximum redemption threshold may allow the company to complete a business combination that a majority of shareholders do not agree with [223]. - If the company does not complete its initial business combination within the required time, public shareholders may receive approximately $10.20 per share upon liquidation of the trust account [230]. - The company may face challenges in completing simultaneous business combinations with multiple targets, increasing costs and risks [219]. - The company may pursue business combinations with private companies that have limited public information, potentially leading to less profitable outcomes [220]. - The company has not yet entered into a definitive agreement with any specific target business, making it difficult to ascertain capital requirements for any particular transaction [231]. Management and Governance - The company’s management plans to address capital needs are discussed in the "Management's Discussion and Analysis" section of the report [212]. - Initial shareholders beneficially own 20% of the issued and outstanding ordinary shares, potentially exerting substantial influence over shareholder votes [232]. - The company relies on a small group of executive officers and directors, and their loss could negatively impact the ability to complete the initial business combination [258]. - Key personnel may negotiate employment agreements that could create conflicts of interest in selecting target businesses [261]. - The company does not have a policy prohibiting directors and officers from having financial interests in transactions, which may lead to conflicts of interest [268]. - The company may qualify as a "controlled company" under Nasdaq rules, allowing it to opt out of certain corporate governance requirements [283]. Market and Regulatory Environment - The ongoing military conflict in Ukraine has increased financial market volatility, potentially affecting the company's ability to identify and consummate a business combination [239]. - Future operations may be significantly impacted by the economic, political, and social conditions of the country where the company operates, potentially affecting demand and profitability [256]. - Exchange rate fluctuations may adversely affect the financial condition and results of operations if a non-U.S. target is acquired, as revenues would likely be in foreign currency [257]. - The company is subject to evolving regulations that have increased general and administrative expenses, diverting management's focus from seeking business combination targets [252]. - After the initial business combination, a majority of directors and officers may reside outside the U.S., complicating enforcement of legal rights for U.S. investors [280]. Securities and Shareholder Impact - The company must maintain certain financial and share price levels to remain listed on Nasdaq, including a minimum share price of $4.00 and at least 300 public holders [272]. - The company may face significant adverse consequences if Nasdaq delists its securities, including potential regulation in each state where securities are offered [273]. - A limited market for the company's securities could adversely affect liquidity and price, with the potential for significant price variation due to business combinations and market conditions [274]. - The company has the ability to amend warrant terms with the approval of at least 50% of outstanding public warrants, which could adversely affect holders [285]. - The company may redeem outstanding public warrants at a price of $0.01 per warrant if certain conditions are met, potentially disadvantaging warrant holders [293]. - The company is not currently registering Class A ordinary shares issuable upon exercise of the warrants under the Securities Act, which may limit investors' ability to exercise their warrants [297]. Tax and Compliance Considerations - Reincorporation in another jurisdiction in connection with the initial business combination may result in tax implications for shareholders [250]. - The company may become a passive foreign investment company (PFIC), which could result in adverse U.S. federal income tax consequences for U.S. investors [305]. - The company is classified as an emerging growth company, allowing it to take advantage of certain exemptions from disclosure requirements, which may affect the attractiveness of its securities to investors [309]. - The company has not engaged in any hedging activities since its inception [379]. - The company does not expect to engage in any hedging activities regarding market risk exposure [379].

Healthcare AI Acquisition Corp.(HAIAU) - 2021 Q4 - Annual Report - Reportify